They are more likely to die from disease. They are more likely to die from violence. They are more likely to die as they age. And they don’t live nearly as long. The life expectancy of people with ...

Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) use was significantly associated with a reduced odds of five-year mortality, but this protective effect was found to be statistically significant ...

Public health experts warn that a major communication failure could worsen mistrust of vaccines, a problem brought to light ...

Independence Blue Cross's Medicare Advantage plans received 4 out of 5 stars from CMS for 2026, excelling in customer service and preventive care. The CMS Star Rating Program evaluates plans on up to ...

The investigators found that one laboratory value—elevated erythrocyte sedimentation rate (ESR)—was also tied with longer ...

Orforglipron is Lilly’s oral GLP-1 in phase 3 development as a treatment for diabetes and obesity. The FDA is expected to approve the drug in March 2026. Lilly’s November news release states that the ...

Melanoma affects nearly 100,000 Americans annually and caused close to 8,000 deaths in 2023. Early detection significantly ...

The revision, made to the CDC’s “Autism and Vaccines” page, now says that the claim “vaccines do not cause autism” is not ...

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

Researchers found that 46% of perimenopausal women reported that masturbation improved at least one of their menopause symptoms, including elevated mood (43%), increased sex drive (13%), improved ...

The American Gastroenterological Association has released updated guidelines for treating moderate-to-severe Crohn’s disease, outlining 16 evidence-based recommendations that prioritize advanced ...

WHO emphasizes integrating surveillance into national STI programs. Zoliflodacin, a novel antimicrobial agent, shows promise in treating gonorrhea, demonstrating non-inferiority to ...